BIOAVAILABILITY OF DRUG PRODUCTS

被引：15
|
作者：
DITTERT, LW
DISANTO, AR
机构：
[1] UNIV KENTUCKY,COLL PHARM,DIV PHARM,LEXINGTON,KY 40506
[2] VP JOHN CO,CLIN SERV CLIN BIOAVAILABIL UNIT,LEXINGTON,KY
来源：
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION | 1973年 / NS13卷 / 08期
关键词：
D O I：
10.1016/S0003-0465(16)32690-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：421 / 432
页数：12
相关论文
共 50 条
  • [41] Advances in drug delivery: Improved bioavailability and drug effect
    Dmochowski R.R.
    Staskin D.R.
    Current Urology Reports, 2002, 3 (6) : 439 - 444
  • [42] Relative bioavailability of two drug products of somatropin obtained from the milk of transgenic cows and from bacterial culture
    Javier, F.
    Feleder, E.
    Gonzalez, E.
    Halabe, K.
    Criscuolo, M.
    Bergada, I.
    Diez, R.
    HORMONE RESEARCH, 2008, 70 : 18 - 18
  • [43] Relative Bioavailability of Two Drug Products of Somatropin Obtained from Either the Milk of Transgenic Cows or Bacterial Culture
    Farias, J.
    Feleder, E.
    Gonzalez, E.
    Halabe, K.
    Criscuolo, M. E.
    Bergada, I.
    Diez, R. A.
    HORMONE RESEARCH IN PAEDIATRICS, 2010, 73 (04): : 258 - 264
  • [44] Relative lung and systemic bioavailability of sodium cromoglycate inhaled products using urinary drug excretion post inhalation
    Aswania, O
    Chrystyn, H
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2002, 23 (04) : 159 - 163
  • [45] SIGNIFICANCE OF BIOAVAILABILITY - FOOD AND DRUG ADMINISTRATION
    SIMMONS, HE
    PHARMACOLOGY, 1972, 8 (1-3) : 206 - 207
  • [46] Biological models to assess drug Bioavailability
    Borchardt, RT
    PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH: BIOLOGICAL, PHYSICOCHEMICAL, AND COMPUTATIONAL STRATEGIES, 2001, : 117 - 126
  • [47] Polymers Enhancing Bioavailability in Drug Delivery
    Fernandes, Ana I.
    Jozala, Angela F.
    PHARMACEUTICS, 2022, 14 (10)
  • [48] DRUG BIOAVAILABILITY DATA - (UN)AVAILABLE
    CAPOMACCHIA, AC
    NEEDHAM, TE
    KOTZAN, JA
    STROM, JG
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1979, 43 (03) : 231 - 233
  • [49] DRUG-COMBINATIONS AND THE BIOAVAILABILITY OF RIFAMPICIN
    ACOCELLA, G
    TUBERCLE AND LUNG DISEASE, 1992, 73 (04): : 242 - 244
  • [50] THE RAT AS A DRUG RESIDUE BIOAVAILABILITY MODEL
    GALLOTORRES, HE
    DRUG METABOLISM REVIEWS, 1990, 22 (6-8) : 707 - 751
12345